The Synergy Between Deep Learning and Organs-on-Chips for High-Throughput Drug Screening: A Review
Overview
Authors
Affiliations
Organs-on-chips (OoCs) are miniature microfluidic systems that have arguably become a class of advanced in vitro models. Deep learning, as an emerging topic in machine learning, has the ability to extract a hidden statistical relationship from the input data. Recently, these two areas have become integrated to achieve synergy for accelerating drug screening. This review provides a brief description of the basic concepts of deep learning used in OoCs and exemplifies the successful use cases for different types of OoCs. These microfluidic chips are of potential to be assembled as highly potent human-on-chips with complex physiological or pathological functions. Finally, we discuss the future supply with perspectives and potential challenges in terms of combining OoCs and deep learning for image processing and automation designs.
Targeted Cancer Therapy-on-A-Chip.
Abed H, Radha R, Anjum S, Paul V, AlSawaftah N, Pitt W Adv Healthc Mater. 2024; 13(29):e2400833.
PMID: 39101627 PMC: 11582519. DOI: 10.1002/adhm.202400833.
Crouzet A, Lopez N, Riss Yaw B, Lepelletier Y, Demange L Molecules. 2024; 29(12).
PMID: 38930784 PMC: 11206022. DOI: 10.3390/molecules29122716.
Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications.
Harun-Ur-Rashid M, Jahan I, Foyez T, Imran A Micromachines (Basel). 2023; 14(9).
PMID: 37763949 PMC: 10536921. DOI: 10.3390/mi14091786.
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics.
Ranjbar S, Zhong X, Manautou J, Lu X Adv Drug Deliv Rev. 2023; 201:115052.
PMID: 37567502 PMC: 10543595. DOI: 10.1016/j.addr.2023.115052.